REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 209 filers reported holding REATA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $744,308 | +12.1% | 7,300 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $663,716 | +178.9% | 7,300 | -19.2% | 0.00% | – |
| Q4 2021 | $238,000 | -78.6% | 9,030 | -18.1% | 0.00% | -100.0% |
| Q3 2021 | $1,110,000 | -28.9% | 11,030 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,561,000 | +38.3% | 11,030 | -2.6% | 0.00% | 0.0% |
| Q1 2021 | $1,129,000 | -19.4% | 11,330 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,400,000 | +59.1% | 11,330 | +25.5% | 0.00% | 0.0% |
| Q3 2020 | $880,000 | -81.7% | 9,030 | -70.7% | 0.00% | -83.3% |
| Q2 2020 | $4,803,000 | +48.4% | 30,783 | +37.2% | 0.01% | +50.0% |
| Q1 2020 | $3,237,000 | -2.6% | 22,429 | +38.0% | 0.00% | +33.3% |
| Q4 2019 | $3,322,000 | – | 16,251 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |